Qol Holdings CoTSE:3034 +1.98%87 Market Cap is 円71,660 Mil as of Jul. 02, 2026. GuruFocus rates TSE:3034 with a GF Score™ of 87/100 and a GF Value™ of 円2,277.20 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 695 Healthcare Providers & Services companies, Qol Holdings Co ranks better than 69.35% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Qol Holdings Co's share price for the quarter that ended in Mar. 2026 was 円1864. Qol Holdings Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 38 Mil. Therefore, Qol Holdings Co's market cap for the quarter that ended in Mar. 2026 was 円70,045 Mil.
Qol Holdings Co's quarterly market cap
increased
from Sep. 2025 (円75,374 Mil) to Dec. 2025 (円80,251 Mil) but then
declined
from Dec. 2025 (円80,251 Mil) to Mar. 2026 (円70,045 Mil).
Qol Holdings Co's annual market cap
increased
from Mar. 2024 (円66,247 Mil) to Mar. 2025 (円67,933 Mil) and
increased
from Mar. 2025 (円67,933 Mil) to Mar. 2026 (円70,045 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Qol Holdings Co's Enterprise Value for Today is 円90,127 Mil.
Qol Holdings Co (TSE:3034) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Qol Holdings Co Market Cap Related Terms
Qol Holdings Co Market Cap Historical Data
* Premium members only.
The historical data trend for Qol Holdings Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Qol Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qol Holdings Co Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Qol Holdings Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Qol Holdings Co's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qol Holdings Co (TSE:3034) has a Market Cap of 円71,660 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Qol Holdings Co and its competitors. According to the industry distribution chart, Qol Holdings Co ranks #213 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 30.6%.
Is Qol Holdings Co's Market Cap too high?
Qol Holdings Co's current Market Cap is 円71,660 Mil. Based on the distribution chart, Qol Holdings Co ranks #213 out of 695 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Qol Holdings Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qol Holdings Co's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qol Holdings Co ranks #213 out of 695 companies for Market Cap. This puts Qol Holdings Co in the upper half of its industry. The industry median Market Cap is 96.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 96.57, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Qol Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 96.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qol Holdings Co's current Market Cap is 円71,660 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qol Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Qol Holdings Co (TSE:3034) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,277.20, compared to a current price of 円1,907.00 — trading 16.3% below its estimated fair value. The current Market Cap is 円71,660 Mil. Qol Holdings Co's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Qol Holdings Co (TSE:3034), the current Market Cap is 円71,660 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qol Holdings Co (TSE:3034) Overvalued in 2026?
Based on GuruFocus' analysis, Qol Holdings Co stock appears to be undervalued.
The current stock price of 円1,907.00 is trading 16.3% below its estimated GF Value™ of 円2,277.20.
GuruFocus considers Qol Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:3034:
Market Cap: 円71,660 Mil
GF Value™: 円2,277.20 vs. price of 円1,907.00 (16.3% below fair value)
No single metric tells the full story. See the TSE:3034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.
87GF Score
Get the complete analysis for TSE:3034
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3034 has been successfully added to your 
